MeSH term
Frequency | Condition_Probility | Blotting, Western | 3 | 0.0 |
Female | 3 | 0.0 |
Gene Expression | 4 | 0.0 |
Humans | 13 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Male | 3 | 0.0 |
Neuropilin-1 | 4 | 7.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Receptors, Vascular Endothelial Growth Factor | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 10 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 5 | 0.0 |
Up-Regulation | 3 | 0.0 |
Animals | 10 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Mice | 4 | 0.0 |
Protein Binding | 2 | 0.0 |
RNA, Messenger/metabolism | 4 | 0.0 |
Receptor Protein-Tyrosine Kinases/metabolism | 2 | 0.0 |
Receptors, Growth Factor/metabolism | 2 | 1.0 |
Signal Transduction | 2 | 0.0 |
Time Factors | 2 | 0.0 |
Vascular Endothelial Growth Factor A | 3 | 0.0 |
Vascular Endothelial Growth Factors | 3 | 0.0 |
Amino Acid Sequence | 2 | 0.0 |
Base Sequence | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Molecular Sequence Data | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 6 | 0.0 |
Neovascularization, Pathologic/*metabolism | 2 | 1.0 |
Prognosis | 3 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Mice, Nude | 2 | 0.0 |
Neuropilin-1/*physiology | 2 | 40.0 |
